Published in Nat Med on June 13, 2010
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
An overview of tissue and whole organ decellularization processes. Biomaterials (2011) 4.78
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules. Ann Thorac Surg (2012) 1.75
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66
Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A (2011) 1.65
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun (2014) 1.60
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
Biomimetic platforms for human stem cell research. Cell Stem Cell (2011) 1.58
Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods (2012) 1.54
Tissue matrix arrays for high-throughput screening and systems analysis of cell function. Nat Methods (2015) 1.52
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev (2013) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng Part A (2011) 1.26
Cell therapies for liver diseases. Liver Transpl (2012) 1.24
Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant (2014) 1.24
Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest (2012) 1.22
A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21
Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology (2012) 1.21
Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A (2014) 1.18
Functional tooth regeneration using a bioengineered tooth unit as a mature organ replacement regenerative therapy. PLoS One (2011) 1.17
Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach. Cell Transplant (2012) 1.17
Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering. Biomaterials (2013) 1.16
Perfusion decellularization of whole organs. Nat Protoc (2014) 1.15
Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomaterials (2011) 1.12
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc (2014) 1.10
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
3D Printed Surgical Instruments: The Design and Fabrication Process. World J Surg (2016) 1.07
Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device. Biomicrofluidics (2011) 1.04
Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model. Eur Cell Mater (2012) 1.03
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03
Will regenerative medicine replace transplantation? Cold Spring Harb Perspect Med (2013) 1.00
Breathing new life into lung transplantation therapy. Mol Ther (2010) 0.99
Liver regeneration. Transl Res (2014) 0.99
Automated decellularization of intact, human-sized lungs for tissue engineering. Tissue Eng Part C Methods (2015) 0.98
A review of cellularization strategies for tissue engineering of whole organs. Front Bioeng Biotechnol (2015) 0.97
Proteomic analysis of a decellularized human vocal fold mucosa scaffold using 2D electrophoresis and high-resolution mass spectrometry. Biomaterials (2012) 0.97
Renal tissue engineering with decellularized rhesus monkey kidneys: age-related differences. Tissue Eng Part A (2011) 0.97
The billion cell construct: will three-dimensional printing get us there? PLoS Biol (2014) 0.96
The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J (2012) 0.95
Liver bioengineering: current status and future perspectives. World J Gastroenterol (2012) 0.95
Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering. Biomaterials (2014) 0.95
Decellularized scaffolds as a platform for bioengineered organs. Curr Opin Organ Transplant (2014) 0.94
An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation. Tissue Eng Part A (2011) 0.94
Comparison of methods for whole-organ decellularization in tissue engineering of bioartificial organs. Tissue Eng Part B Rev (2012) 0.94
The effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomater (2013) 0.93
Material strategies for creating artificial cell-instructive niches. Curr Opin Biotechnol (2012) 0.93
Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93
Cell-derived matrices for tissue engineering and regenerative medicine applications. Biomater Sci (2015) 0.92
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg (2012) 0.92
Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl (2011) 0.92
Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng Part B Rev (2014) 0.92
Procedure for lung engineering. J Vis Exp (2011) 0.91
Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng (2011) 0.90
Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online (2010) 0.90
Clinical implications of advances in liver regeneration. Clin Mol Hepatol (2015) 0.90
Hydrogels derived from demineralized and decellularized bone extracellular matrix. Acta Biomater (2013) 0.89
Decellularization and recellularization of whole livers. J Vis Exp (2011) 0.89
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med (2014) 0.89
Bioengineering in organ transplantation: targeting the liver. Transplant Proc (2011) 0.89
Application of whole-organ tissue engineering in hepatology. Nat Rev Gastroenterol Hepatol (2012) 0.89
Engineered composite tissue as a bioartificial limb graft. Biomaterials (2015) 0.89
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep (2015) 0.88
A perspective on the clinical translation of scaffolds for tissue engineering. Ann Biomed Eng (2014) 0.88
Strategies for whole lung tissue engineering. IEEE Trans Biomed Eng (2014) 0.87
Functional characterization of detergent-decellularized equine tendon extracellular matrix for tissue engineering applications. PLoS One (2013) 0.87
Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci U S A (2015) 0.86
Dual-Purpose Bioreactors to Monitor Noninvasive Physical and Biochemical Markers of Kidney and Liver Scaffold Recellularization. Tissue Eng Part C Methods (2015) 0.86
Procedure for decellularization of porcine heart by retrograde coronary perfusion. J Vis Exp (2012) 0.86
Generation of functional organs from stem cells. Cell Regen (Lond) (2013) 0.86
Cellular therapy and bioartificial approaches to liver replacement. Curr Opin Organ Transplant (2012) 0.86
Reprogramming antitumor immunity. Trends Immunol (2014) 0.86
Proteomic analysis of naturally-sourced biological scaffolds. Biomaterials (2015) 0.86
Partial characterization of the Sox2+ cell population in an adult murine model of digit amputation. Tissue Eng Part A (2012) 0.86
Detergent enzymatic treatment for the development of a natural acellular matrix for oesophageal regeneration. Pediatr Surg Int (2013) 0.86
Histologic characterization of acellular dermal matrices in a porcine model of tissue expander breast reconstruction. Tissue Eng Part A (2014) 0.85
Promotion of hepatic differentiation of bone marrow mesenchymal stem cells on decellularized cell-deposited extracellular matrix. Biomed Res Int (2013) 0.85
Liver repopulation and regeneration: new approaches to old questions. Curr Opin Organ Transplant (2013) 0.85
A decellularization methodology for the production of a natural acellular intestinal matrix. J Vis Exp (2013) 0.85
Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix. J Clin Exp Hepatol (2014) 0.84
Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering. Tissue Eng Part A (2013) 0.84
Decellularized tendon extracellular matrix-a valuable approach for tendon reconstruction? Cells (2012) 0.84
Extracellular matrix aggregates from differentiating embryoid bodies as a scaffold to support ESC proliferation and differentiation. PLoS One (2013) 0.84
SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS. Cell Med (2013) 0.84
Optimizing perfusion-decellularization methods of porcine livers for clinical-scale whole-organ bioengineering. Biomed Res Int (2015) 0.83
Assembly of human organs from stem cells to study liver disease. Am J Pathol (2013) 0.83
Initiation of puberty in mice following decellularized ovary transplant. Biomaterials (2015) 0.83
Engineering approaches toward deconstructing and controlling the stem cell environment. Ann Biomed Eng (2011) 0.83
Mesenchymal stem cells support hepatocyte function in engineered liver grafts. Organogenesis (2014) 0.83
Heart extracellular matrix supports cardiomyocyte differentiation of mouse embryonic stem cells. J Biosci Bioeng (2012) 0.83
Importance of the stem cell microenvironment for ophthalmological cell-based therapy. World J Stem Cells (2015) 0.82
The clinical effectiveness in wound healing with extracellular matrix derived from porcine urinary bladder matrix: a case series on severe chronic wounds. J Am Col Certif Wound Spec (2010) 0.82
Living bacterial sacrificial porogens to engineer decellularized porous scaffolds. PLoS One (2011) 0.82
Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci (2015) 0.81
Controlled assembly of heterotypic cells in a core-shell scaffold: organ in a droplet. Lab Chip (2016) 0.81
Tissue engineering. Science (1993) 19.65
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Clinical transplantation of a tissue-engineered airway. Lancet (2008) 10.04
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog (1991) 3.21
The extracellular matrix as a biologic scaffold material. Biomaterials (2007) 3.18
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med (2007) 1.96
Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant (2003) 1.91
Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology (1998) 1.83
Cell transplantation in the treatment of liver diseases. Pediatr Transplant (2008) 1.75
Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation (1997) 1.67
Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation (1994) 1.54
Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A (2008) 1.52
Hepatocyte transplantation. J Hepatol (2004) 1.50
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
Integration of technologies for hepatic tissue engineering. Adv Biochem Eng Biotechnol (2007) 1.43
Engraftment of a vascularized human skin equivalent. FASEB J (2003) 1.43
Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology (2006) 1.39
Hepatic tissue engineering. Transpl Immunol (2004) 1.36
Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J (2007) 1.34
Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation (2009) 1.32
Organ donation and utilization in the United States, 1996-2005. Am J Transplant (2007) 1.28
Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng (2007) 1.24
Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro. Tissue Eng (2006) 1.23
Reinforcement of esophageal anastomoses with an extracellular matrix scaffold in a canine model. Ann Thorac Surg (2006) 1.21
Oxygen consumption characteristics of porcine hepatocytes. Metab Eng (1999) 1.15
Oxygen is a factor determining in vitro tissue assembly: Effects on attachment and spreading of hepatocytes. Biotechnol Bioeng (1994) 1.12
Diluted blood reperfusion as a model for transplantation of ischemic rat livers: alanine aminotransferase is a direct indicator of viability. Transplant Proc (2010) 1.06
Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol (2007) 1.04
Measurement of the synthesis of liver-produced plasma proteins with particular reference to dietary protein and amino acid supply. Biochem J (1972) 0.94
Clinical death symposium. Crit Care Med (1988) 0.92
Optimization of hepatocyte attachment to microcarriers: Importance of oxygen. Biotechnol Bioeng (1993) 0.91
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Hepatic portal venous gas: the ABCs of management. Arch Surg (2009) 3.76
Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (2013) 3.26
Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng (2011) 3.16
Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86
Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell (2010) 2.86
Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One (2007) 2.80
Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (2008) 2.50
Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant (2010) 2.50
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology (2008) 2.45
Supercooling enables long-term transplantation survival following 4 days of liver preservation. Nat Med (2014) 2.31
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol (2005) 2.12
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med (2004) 2.01
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res (2005) 1.99
A high-throughput microfluidic real-time gene expression living cell array. Lab Chip (2006) 1.93
Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology (2010) 1.92
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol (2012) 1.74
Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng (2009) 1.66
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol (2009) 1.64
Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc Natl Acad Sci U S A (2010) 1.63
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest (2015) 1.58
Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells (2008) 1.58
Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci (2006) 1.55
Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal Chem (2006) 1.53
Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A (2008) 1.52
Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.52
Confinement to organelle-associated inclusion structures mediates asymmetric inheritance of aggregated protein in budding yeast. Cell Rep (2012) 1.52
Dynamic gene expression profiling using a microfabricated living cell array. Anal Chem (2004) 1.50
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol (2010) 1.50
Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther (2010) 1.47
Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A (2012) 1.44
Integration of technologies for hepatic tissue engineering. Adv Biochem Eng Biotechnol (2007) 1.43
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res (2004) 1.41
In vitro models of traumatic brain injury. Annu Rev Biomed Eng (2011) 1.38
Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem (2002) 1.38
A model for normothermic preservation of the rat liver. Tissue Eng (2007) 1.38
Nonthermal irreversible electroporation: fundamentals, applications, and challenges. IEEE Trans Biomed Eng (2013) 1.36
Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J (2007) 1.34
Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc Natl Acad Sci U S A (2009) 1.32
Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation (2009) 1.32
Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res (2004) 1.32
Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng (2011) 1.31
Microfabrication-based modulation of embryonic stem cell differentiation. Lab Chip (2007) 1.27
Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun (2007) 1.27
Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng (2007) 1.24
Microfluidic flow-encoded switching for parallel control of dynamic cellular microenvironments. Lab Chip (2007) 1.23
Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc (2007) 1.22
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol (2008) 1.19
Designing a hepatocellular microenvironment with protein microarraying and poly(ethylene glycol) photolithography. Langmuir (2004) 1.17
DNA-triggered innate immune responses are propagated by gap junction communication. Proc Natl Acad Sci U S A (2009) 1.17
Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach. Cell Transplant (2012) 1.17
Ductal injection of preservation solution increases islet yields in islet isolation and improves islet graft function. Cell Transplant (2008) 1.16
Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells. Cancer Res (2007) 1.16
Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks. Ann Biomed Eng (2007) 1.15
Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes. Hepatology (2006) 1.14
HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response. PLoS One (2011) 1.13
Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation (2004) 1.12
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol (2012) 1.11
Optimization of reporter cells for expression profiling in a microfluidic device. Biomed Microdevices (2005) 1.10
Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen (2012) 1.10
A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation. Transplant Res (2012) 1.10
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08
Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA. Biophys J (2002) 1.08
Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One (2010) 1.07
The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis. Hepatology (2012) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Microfluidics and multielectrode array-compatible organotypic slice culture method. J Neurosci Methods (2008) 1.07
Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation. J Surg Res (2011) 1.06
Cell delivery: from cell transplantation to organ engineering. Cell Transplant (2010) 1.06